End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.41 CNY | -2.29% | -7.90% | -33.78% |
Apr. 29 | Daan Gene Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Daan Gene Gets Nod to Register Detection Kit for Influenza Viruses, COVID-19 | MT |
Sales 2022 | 12.05B 1.66B | Sales 2023 | 1.18B 163M | Capitalization | 13.59B 1.88B |
---|---|---|---|---|---|
Net income 2022 | 5.41B 747M | Net income 2023 | 105M 14.49M | EV / Sales 2022 | 1.54 x |
Net cash position 2022 | 3.33B 460M | Net cash position 2023 | 2.03B 281M | EV / Sales 2023 | 9.78 x |
P/E ratio 2022 |
4.03
x | P/E ratio 2023 |
130
x | Employees | 1,968 |
Yield 2022 |
11.2% | Yield 2023 |
0.15% | Free-Float | 65.64% |
1 day | -2.29% | ||
1 week | -7.90% | ||
Current month | -8.30% | ||
1 month | -14.19% | ||
3 months | -26.83% | ||
6 months | -37.89% | ||
Current year | -33.78% |
Managers | Title | Age | Since |
---|---|---|---|
Luo Huang
CEO | Chief Executive Officer | 44 | 21-05-31 |
Wei Jie Zhang
DFI | Director of Finance/CFO | 53 | 15-03-25 |
Xi Wen Jiang
BRD | Director/Board Member | 42 | 21-06-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Zheng Fu Zhu
BRD | Director/Board Member | 60 | 22-05-26 |
Zhe Qiang Xue
CHM | Chairman | 36 | 22-07-03 |
Li Qiang Huang
BRD | Director/Board Member | 57 | 03-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.37% | 2 M€ | -17.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 6.41 | -2.29% | 10,161,610 |
24-05-27 | 6.56 | -1.65% | 12,664,480 |
24-05-24 | 6.67 | -1.19% | 9,928,889 |
24-05-23 | 6.75 | -2.03% | 11,318,200 |
24-05-22 | 6.89 | +0.44% | 8,666,465 |
End-of-day quote Shenzhen S.E., May 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-33.78% | 1.27B | |
-19.14% | 56.5M |
- Stock Market
- Equities
- 002030 Stock